Sinopharm Group Co.-Unsp ADRSHTDY
13F holders, Q4 2025 (December 31)4holders +1
1new positions
0sold out
$12.40avg. 13F price*
At the end of Q4 2025, 4 institutions reported holding Sinopharm Group Co.-Unsp ADR (SHTDY) in their 13F filings, up 1 from Q3 2025. 1 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($14K), PNC Financial Services Group, Inc. ($4K) and GAMMA Investing LLC ($2K).
- Company
- Sinopharm Group Co.-Unsp ADR
- CUSIP
- 82937K101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $421 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 88 shares bought and 23 shares sold, net +65 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Rhumbline Advisers | 0.00% | No change | 1,101 | $14K |
| PNC Financial Services Group, Inc. | 0.00% | Add +23.2% | 287 | $4K |
| GAMMA Investing LLC | 0.00% | Reduce -11.2% | 182 | $2K |
| IMA Advisory Services, Inc. | 0.00% | New | 34 | $421 |
"% of holder's portfolio" is SHTDY's weight in each manager's 13F, not the share of Sinopharm Group Co.-Unsp ADR the manager owns.